Immediate and Gradual Withdrawal of Immunosuppression After Kidney Graft Loss Lead to Similar Outcomes
Transplant International · 2026
DOI: 10.3389/ti.2026.15642 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, 2026. Verfasst von Asmaa Nabil und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Organ Transplantation, CHU de Toulouse, Toulouse, France. Hauptthemen laut MEDLINE: Kidney Transplantation, Immunosuppressive Agents, Graft Rejection, Immunosuppression Therapy. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The management of immunosuppression in dialysis patients with a failed kidney transplant remains a pending question, and different approaches to immunosuppression weaning have been proposed. We conducted a retrospective study of patients who experienced a graft failure, and compared the rates of immune and non-immune events, according to different modalities of immunosuppression withdrawal. Two hundred and eighteen patients were included. During the follow-up (45 (20–80) months post-graft failure), 53 patients (24.3%) experienced an intolerance syndrome. The time between graft failure and the occurrence of intolerance syndrome was 6 (3–13) months. Immunosuppression withdrawal was associated with the occurrence of intolerance syndrome. However, regarding the immunosuppression withdrawal modality, only a steroid cessation during the first 3 months post graft failure was independently associated with an earlier occurrence of intolerance syndrome [HR = 1.91, 95%CI (1.08–3.38), p = 0.025], while a longer time between transplantation to graft failure was independently associated with a delayed occurrence of intolerance syndrome [HR = 0.99, 95%CI (0.98–0.99), p = 0.009]. The immunosuppression withdrawal modality after graft failure didn’t have an impact on infections and cardiovascular complications. Although discontinuation of immunosuppression strongly influences the occurrence of intolerance syndrome, immunosuppression withdrawal modality itself does not appear to.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Organ Transplantation, CHU de Toulouse, Toulouse, France.
- Centre Hospitalier et Universitaire, Université Paul Sabatier Toulouse III, Toulouse, France.
- Laboratory of Immunology, Biology Department, Centre Hospitalier et Universitaire (CHU) de Toulouse, Toulouse, France.
- Institute of Metabolic and Cardiovascular Diseases (I2MC), Institut National de la Santé et de la Recherche Médicale (INSERM) U1297, University of Toulouse 3, Toulouse, France.
- Department of Urology and Renal Transplantation, CHU de Toulouse, Toulouse, France.
- Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1043-CNRS 5282, Toulouse, France.
Zitieren
APA
Nabil, A., Congy-Jolivet, N., Darres, A., Guy, P., Marion, O., Milhes, J., Prudhomme, T., Kamar, N., & Del Bello, A. (2026). Immediate and Gradual Withdrawal of Immunosuppression After Kidney Graft Loss Lead to Similar Outcomes. Transplant International. https://doi.org/10.3389/ti.2026.15642
Vancouver
Nabil A, Congy-Jolivet N, Darres A, Guy P, Marion O, Milhes J, et al. Immediate and Gradual Withdrawal of Immunosuppression After Kidney Graft Loss Lead to Similar Outcomes. Transplant International. 2026. doi:10.3389/ti.2026.15642
BibTeX
@article{Nabil2026,
author = {Nabil, Asmaa and Congy-Jolivet, Nicolas and Darres, Amandine and Guy, Pierre and Marion, Olivier and Milhes, Jean and Prudhomme, Thomas and Kamar, Nassim and Del Bello, Arnaud},
title = {Immediate and Gradual Withdrawal of Immunosuppression After Kidney Graft Loss Lead to Similar Outcomes},
journal = {Transplant International},
year = {2026},
doi = {10.3389/ti.2026.15642}
}
EUVIMED